Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Ventures Llc Syntone currently holds 1,071,429 shares of Outlook Therapeutics, Inc. (OTLK), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Ventures Llc Syntone has been a net buyer of OTLK stock. They have purchased $4.0M and sold $0 worth of shares.
Ventures Llc Syntone's most recent insider trade was on Apr 15, 2024, when they purchased 1,071,429 shares at $0.00 per share.
Ventures Llc Syntone serves as Executive at Outlook Therapeutics, Inc. (OTLK). They have executed 4 insider transactions totaling $4.0M over their tenure at the company.
Ventures Llc Syntone holds the position of Executive at Outlook Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 6 years and currently hold a stake valued at $0.
Ventures Llc Syntone has shown a buying trading pattern, with $4.0M in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Ventures Llc Syntone was on Feb 3, 2021, when they purchased $3.0M worth of OTLK shares. This transaction involved 3,000,000 shares at $1.00 per share.
Ventures Llc Syntone currently owns 1,071,429 shares of Outlook Therapeutics, Inc. (OTLK), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Ventures Llc Syntone's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Ventures Llc Syntone has 4 Form 4 filings on record as an insider at Outlook Therapeutics, Inc..
Set alerts for Ventures Llc Syntone and 40,000+ other insiders.